Asia Oceania Journal of Nuclear Medicine and Biology
AOJNMB
Medical Sciences
https://aojnmb.mums.ac.ir/
0
2322-5718
2322-5726
en
jalali
0
0
1
gregorian
2018
7
1
6
2
online
1
fulltext
en
Feasibility of high-dose iodine-131-metaiodobenzylguanidine therapy for high-risk neuroblastoma preceding myeloablative chemotherapy and hematopoietic stem cell transplantation: a study protocol
Others
131I-MIBG, Neuroblastoma, Hematopoietic stem cell transplantation, Prospective study protocol
161
166
https://aojnmb.mums.ac.ir/article_10769.html
Raita
Araki
raraki@staff.kanazawa-u.ac.jp
44976
Yes
Department of Pediatrics, School of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Japan
Ryosei
Nishimura
ryosein@staff.kanazawa-u.ac.jp
44977
No
Department of Pediatrics, School of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Japan
Anri
Inaki
henri@staff.kanazawa-u.ac.jp
44978
No
Department of Nuclear Medicine, School of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Japan
Hiroshi
Wakabayashi
wakabayashi@staff.kanazawa-u.ac.jp
44979
No
Department of Nuclear Medicine, School of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Japan
Yasuhito
Imai
imaiya@staff.kanazawa-u.ac.jp
44980
No
Innovative Clinical Research Center, Kanazawa University, Japan
Yoshikazu
Kuribayashi
kuribayashi@staff.kanazawa-u.ac.jp
44981
No
Innovative Clinical Research Center, Kanazawa University, Japan
Kenichi
Yoshimura
keyoshim@staff.kanazawa-u.ac.jp
44982
No
Innovative Clinical Research Center, Kanazawa University, Japan
Toshinori
Murayama
toshi@staff.kanazawa-u.ac.jp
44983
No
Innovative Clinical Research Center, Kanazawa University, Japan
Seigo
Kinuya
kinuya@med.kanazawa-u.ac.jp
44984
No
Department of Nuclear Medicine, School of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Japan